首页> 美国卫生研究院文献>Cancer Informatics >Mouse 11β-Hydroxysteroid Dehydrogenase Type 2 for Human Application: Homology Modeling Structural Analysis and Ligand-Receptor Interaction
【2h】

Mouse 11β-Hydroxysteroid Dehydrogenase Type 2 for Human Application: Homology Modeling Structural Analysis and Ligand-Receptor Interaction

机译:适用于人类的小鼠11β-羟基类固醇脱氢酶2:同源性建模结构分析和配体-受体相互作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mouse (m) 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2) was homology-modeled, and its structure and ligand-receptor interaction were analyzed. The modeled m11βHSD2 showed significant 3D similarities to the human (h) 11βHSD1 and 2 structures. The contact energy profiles of the m11βHSD2 model were in good agreement with those of the h11βHSD1 and 2 structures. The secondary structure of the m11βHSD2 model exhibited a central 6-stranded all-parallel β-sheet sandwich-like structure, flanked on both sides by 3-helices. Ramachandran plots revealed that only 1.1% of the amino acid residues were in the disfavored region for m11βHSD2. Further, the molecular surfaces and electrostatic analyses of the m11βHSD2 model at the ligand-binding site exhibited that the model was almost identical to the h11βHSD2 model. Furthermore, docking simulation and ligand-receptor interaction analyses revealed the similarity of the ligand-receptor bound conformation between the m11βHSD2 and h11βHSD2 models. These results indicate that the m11βHSD2 model was successfully evaluated and analyzed. To the best of our knowledge, this is the first report of a m11βHSD2 model with detailed analyses, and our data verify that the mouse model can be utilized for application to the human model to target 11βHSD2 for the development of anticancer drugs.
机译:对小鼠(m)2型11β-羟基类固醇脱氢酶(11βHSD2)进行了同源建模,并对其结构和配体-受体相互作用进行了分析。建模的m11βHSD2与人类(h)11βHSD1和2结构表现出显着的3D相似性。 m11βHSD2模型的接触能谱与h11βHSD1和2结构的接触能谱非常吻合。 m11βHSD2模型的二级结构表现出中心6链全平行β-折叠三明治样结构,在两侧均带有3个螺旋。 Ramachandran图显示,m11βHSD2的不利区域只有1.1%的氨基酸残基。此外,m11βHSD2模型在配体结合位点的分子表面和静电分析表明,该模型与h11βHSD2模型几乎相同。此外,对接模拟和配体-受体相互作用分析揭示了m11βHSD2和h11βHSD2模型之间的配体-受体结合构象的相似性。这些结果表明,m11βHSD2模型已成功评估和分析。据我们所知,这是首次对m11βHSD2模型进行详细分析,并且我们的数据验证了该小鼠模型可用于人类模型,并将11βHSD2靶向用于开发抗癌药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号